Clinical Trial Update: A Study of Usage of Paliperidone Palmitate in Patients With Schizophrenia in a Hospital Setting

View source ↗

Summary

A completed clinical trial evaluating the usage of paliperidone palmitate for schizophrenia in a hospital setting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• INVEGA SUSTENNA (PALIPERIDONE PALMITATE)

Snippet

Sponsor: Janssen-Cilag International NV | Conditions: Schizophrenia | Status: COMPLETED